The Global Glucose Monitoring Devices Market was valued at USD 15.8 Billion in 2023 and is projected to reach USD 26.4 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 10.8% during the forecast period (2023–2028). This significant growth is fueled by the rising global prevalence of diabetes, increasing demand for continuous glucose monitoring (CGM) systems, and the accelerated adoption of digital health technologies for chronic disease management.

As the healthcare industry shifts toward personalized, data-driven patient care, the focus intensifies on the key medical device manufacturers who are pioneering advancements in accuracy, connectivity, and user experience. In this blog, we profile the Top 10 Companies in the Glucose Monitoring Devices Industry—a combination of established medtech giants and innovative disruptors shaping the future of diabetes care.

Download FREE Sample Report:
2023-2028 Global and Regional Glucose Monitoring Devices Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🔟 1. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: FreeStyle Libre CGM Systems

Abbott is a global leader in glucose monitoring, renowned for its revolutionary FreeStyle Libre portfolio. The flash glucose monitoring system eliminates the need for routine fingersticks, providing patients with real-time glucose data through a wearable sensor and reader or smartphone app.

Innovation & Market Leadership:

• Dominant market share in the rapidly growing CGM segment

• Continuous product iterations, including the FreeStyle Libre 3 with real-time alerts

• Extensive insurance coverage and global market penetration

---

9️⃣ 2. DexCom, Inc.

Headquarters: San Diego, California, USA
Key Offering: Dexcom G6 and G7 CGM Systems

DexCom specializes exclusively in CGM technology and is widely regarded for its high-accuracy, real-time systems. The Dexcom G7, its latest generation, offers a smaller form factor, simplified insertion, and enhanced connectivity for seamless diabetes management.

Innovation & Market Leadership:

• Pioneer in real-time CGM with strong clinical validation

• Strategic integrations with insulin pumps and digital health platforms

---

8️⃣ 3. Roche Diabetes Care

Headquarters: Basel, Switzerland
Key Offering: Accu-Chek blood glucose monitoring systems

Roche Diabetes Care is a stalwart in the traditional blood glucose monitoring (BGM) market with its Accu-Chek brand. The company is actively expanding its digital ecosystem with connected meters, data management software, and personalized coaching services.

Innovation & Market Leadership:

• Strong brand loyalty and presence in hospital and retail channels

• Focus on integrated personalized diabetes management (iPDM) solutions

Download FREE Sample Report:
2023-2028 Global and Regional Glucose Monitoring Devices Industry Status and Prospects Professional Market – View in Detailed Research Report

---

7️⃣ 4. Medtronic plc

Headquarters: Dublin, Ireland
Key Offering: MiniMed insulin pumps with Guardian CGM

Medtronic is a key player in the automated insulin delivery (AID) space, combining its CGM technology with insulin pumps to create hybrid closed-loop systems. Its MiniMed 780G system is designed to automatically adjust insulin delivery, simplifying management for users.

Innovation & Market Leadership:

• Leader in integrated AID systems for Type 1 diabetes

• Ongoing R&D focused on predictive algorithms and smarter automation

---

6️⃣ 5. LifeScan (a subsidiary of Platinum Equity)

Headquarters: Malvern, Pennsylvania, USA
Key Offering: OneTouch blood glucose monitoring systems

LifeScan, known for its iconic OneTouch brand, is a major force in the BGM market. The company continues to innovate with Bluetooth-enabled meters like the OneTouch Verio Reflect®, which provides patterns and insights to help users understand their glucose trends.

Innovation & Market Leadership:

• Extensive global distribution network and brand recognition

• Digital health focus with apps that offer personalized feedback

---

5️⃣ 6. B. Braun Melsungen AG

Headquarters: Melsungen, Germany
Key Offering: Glucose monitoring systems for hospital and home use

B. Braun is a prominent medical device company with a significant presence in hospital diabetes care. It offers a range of blood glucose monitoring systems designed for both clinical settings and individual patient use, emphasizing safety and accuracy.

Innovation & Market Leadership:

• Strong foothold in the hospital and institutional care segment

• Integration of glucose monitoring with its broader infusion therapy portfolio

---

4️⃣ 7. ASCENSIA Diabetes Care

Headquarters: Basel, Switzerland
Key Offering: CONTOUR® blood glucose monitoring systems

ASCENSIA, formerly the diabetes care division of Bayer, is a globally recognized diabetes company. Its CONTOUR® NEXT portfolio is acclaimed for its accuracy and ease of use, supported by smartphone connectivity for data tracking and analysis.

Innovation & Market Leadership:

• Focus on high-accuracy BGM technology with second-chance sampling

• Global reach with a strong emphasis on user education and support

---

3️⃣ 8. Nova Biomedical Corporation

Headquarters: Waltham, Massachusetts, USA
Key Offering: StatStrip® hospital glucose monitoring systems

Nova Biomedical specializes in critical care and hospital-based glucose testing. Its StatStrip® Glucose Hospital Meter System is the only FDA-cleared system to be不受干扰 by common clinically relevant substances, making it a gold standard in inpatient settings.

Innovation & Market Leadership:

• Market leader in hospital point-of-care glucose testing

• Commitment to reducing medication interference for enhanced patient safety

---

2️⃣ 9. AgaMatrix, Inc.

Headquarters: Salem, New Hampshire, USA
Key Offering: Wavesense Jazz® and POGO® glucose meters

AgaMatrix is a technology innovator known for developing the first FDA-cleared smartphone-connected blood glucose meter. Its technology is also licensed to other major brands, and its POGO® Automatic® Monitor automates lancing and blood collection.

Innovation & Market Leadership:

• Pioneer in smartphone-integrated diabetes management

• Focus on reducing the burden of testing through automation

---

1️⃣ 10. Terumo Corporation

Headquarters: Tokyo, Japan
Key Offering: Blood glucose monitoring systems and diabetes care devices

Terumo is a leading medical device manufacturer with a significant presence in Asia. Its diabetes care division offers reliable blood glucose monitors and a comprehensive suite of products, including insulin syringes and lancets, catering to a broad patient base.

Innovation & Market Leadership:

• Strong regional dominance in the Asia-Pacific market

• Integrated diabetes care solutions from monitoring to drug delivery

Get Full Report Here:
2023-2028 Global and Regional Glucose Monitoring Devices Industry Status and Prospects Professional Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Glucose Monitoring Is Connected and Proactive

The glucose monitoring devices market is experiencing a transformative shift. While traditional BGM devices maintain a substantial user base, the industry is rapidly advancing toward non-invasive monitors, predictive analytics, and fully integrated AID systems that promise to revolutionize diabetes care.

📈 Key Trends Shaping the Market:

• Explosive adoption of CGM systems driven by improved reimbursements and user-friendly designs.

• Increasing integration with digital health platforms, electronic health records (EHRs), and telehealth services.

• R&D focused on long-term implantable sensors and non-invasive technologies.

• Growing emphasis on population health management and preventive care models.

Get Full Report Here:
2023-2028 Global and Regional Glucose Monitoring Devices Industry Status and Prospects Professional Market – View in Detailed Research Report

The companies profiled are not just providing tools for diabetes management—they are actively building the intelligent healthcare ecosystem of tomorrow.